← Leaderboards
Anne M Blackwood-Chirchir
University Of Pennsylvania
$248,605
Attributed
$248,605
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$248,605 · 3
By mechanism
K08$248,605 · 1
P01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Charles P Emerson$35,198,488
- Barbara L Weber$3,752,139
- Lewis A Chodosh$38,386,361
- David J Goldhamer$9,824,473
- Robert H Vonderheide$28,425,019
Others in their field
Top investigators on “Female”
- Philip J Disaia · University Of California Irvine$140,003,514
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$103,542,269
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,372,214
- Myron S Cohen · Family Health International$101,800,876
- Walter John Curran · Thomas Jefferson University$57,608,324
- Gregory S Boebinger · Florida State University$55,673,680
Research focus
FemaleBreast NeoplasmsHuman SubjectClinical ResearchBrca GeneCancer Information SystemCancer PreventionCancer RiskCaucasian AmericanCell CycleChemopreventionClinical TrialsCyclinsDna DamageEstrogensGenetic CarriersHormone MetabolismHormone Related Neoplasm /CancerHuman DataHuman Therapy EvaluationLoss Of HeterozygosityMammographyMedical Outreach /Case FindingNeoplasm /Cancer Epidemiology
Grant awards (9)
MOLECULAR EPIDEMIOLOGY OF BRCA1 RELATED BREAST NEOPLASIA$83,726
K08 · FY2002 · CA
CORE--CLINICAL FACILITY$0
P01 · FY2002 · CA
CANCER RISK AND BIOMARKERS OF TAMOXIFEN CHEMOPREVENTION$0
P01 · FY2002 · CA
MOLECULAR EPIDEMIOLOGY OF BRCA1 RELATED BREAST NEOPLASIA$82,861
K08 · FY2001 · CA
CANCER RISK AND BIOMARKERS OF TAMOXIFEN CHEMOPREVENTION$0
P01 · FY2001 · CA
CORE--CLINICAL FACILITY$0
P01 · FY2001 · CA
MOLECULAR EPIDEMIOLOGY OF BRCA1 RELATED BREAST NEOPLASIA$82,018
K08 · FY2000 · CA
CORE--CLINICAL FACILITY$0
P01 · FY2000 · CA
CANCER RISK AND BIOMARKERS OF TAMOXIFEN CHEMOPREVENTION$0
P01 · FY2000 · CA